Biotech grants in South Korea

Funds one project mining research cohorts and biobanks to find causal links between infections and non-communicable diseases, aimed at new vaccines, diagnostics and early treatments.

Closed

Funds research into how environmental exposures interact with genetic and lifestyle factors to cause cancer in children, adolescents and young adults.

Closed

Funds AI and digital-twin tools that speed up bio-based manufacturing — from biorefinery process control to predicting biosynthesis pathways.

Funds a full-scale flagship biorefinery that turns separately-collected urban bio-waste into higher-value bio-based products instead of compost or biomethane.

Closed

Funds the advancement of existing vaccine candidates against one named epidemic-prone virus, from lab testing through to a first human safety trial.

Funds research into new tools and conversion routes that turn low-value forest residues into bio-based chemicals, materials or products beyond bioenergy.

Open

Funds Korean startups and small and medium-sized enterprises through low-interest loans managed by KOSME and the Ministry of enterprise and innovation support.

Between cycles

Funds Korean startups building products and market access with global companies through open-innovation projects.

Between cycles

Funds Korean venture-stage companies with market-development support and loan guarantees to accelerate scaling.

Between cycles

Funds Korean SMEs entering overseas markets through projects run with companies that already have global channels.

Between cycles

Funds Korean startups solving defined technology problems with large companies and public institutions.

Closed

Supports foreign-founded startups entering Korea with market localization and expansion assistance.

Closed

Funds Korean micro-enterprises turning proven export demand into products, brands, certifications, and overseas sales.

Gives free mentoring and pitch coaching to international student founders building in Korea.

Closed

Funds high-growth Korean technology companies scaling overseas, raising global capital, and preparing for public markets.

Discontinued

Provides collateral-light access to bank financing in Korea through technology-based credit guarantees for innovative startups and small businesses.

Open

Supports Alzheimer’s and dementia drug development from preclinical readiness to early clinical testing across diverse modalities.

Open

Funds new biomarkers for Alzheimer's and related dementias through PET ligands, MRI, spinal fluid, and brain activity measures.

Open

Supports dementia prevention research through precision risk reduction, combination treatment testing, and effectiveness comparisons.

Open

Funds a consortium to build a new EIT Label-certified micro-credentials programme teaching entrepreneurship and innovation to healthcare students.

Funds small, high-risk exploratory research into reconstructive transplantation and vascularized composite allotransplantation for wounded Service Members and Veterans.

Pays $10,000 for a genuinely new way to verify cleanliness in under 30 minutes.

Open

Funds four centres to work out how cancer actually spreads — each on one theme, through two or three interlocking basic research projects.

Open

Supports global cancer teams through CRUK to validate novel therapeutic concepts toward patient solutions.